[et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.16″ da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_slider use_text_overlay=”on” text_overlay_color=”rgba(6,66,58,0.25)” _builder_version=”4.16″ custom_padding=”83px||65px|||” auto=”on” auto_ignore_hover=”on” global_colors_info=”{}”][et_pb_slide heading=”Pacients” use_bg_overlay=”off” use_text_overlay=”on” arrows_custom_color=”#2d788c” dot_nav_custom_color=”#2d788c” text_border_radius=”10px” _builder_version=”4.16″ header_font=”|700|||||||” header_text_align=”center” body_text_align=”center” body_font_size=”30px” background_enable_color=”off” use_background_color_gradient=”on” background_color_gradient_direction=”90deg” background_color_gradient_stops=”rgba(0,0,0,0) 0%|rgba(0,0,0,0) 100%” background_color_gradient_overlays_image=”on” background_color_gradient_start=”rgba(0,0,0,0)” background_color_gradient_end=”rgba(0,0,0,0)” background_image=”https:\/\/www.thervacb.eu\/wp-content\/uploads\/the-thervacb-vaccine-h.jpg” background_enable_image=”on” text_orientation=”center” header_text_shadow_style=”preset1″ header_text_shadow_color=”#706f6f” body_text_shadow_style=”preset1″ body_text_shadow_color=”#706f6f” text_shadow_style=”preset1″ text_shadow_color=”#706f6f” global_colors_info=”{}” sticky_transition=”on”]<\/p>\n
La vacuna TherVacB<\/p>\n
[\/et_pb_slide][\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row module_id=”timelines” _builder_version=”4.16″ global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ global_colors_info=”{}”][et_pb_text _builder_version=”4.25.0″ hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
L’assaig cl\u00ednic presentat anteriorment forma part del projecte TherVacB de la UE. \u00c9s el primer pas per provar la seguretat i l’efic\u00e0cia de la ter\u00e0pia en persones amb hepatitis B cr\u00f2nica. Si aquest assaig t\u00e9 \u00e8xit, seguiran m\u00e9s assajos cl\u00ednics (fase II i III) per completar el desenvolupament cl\u00ednic. Aix\u00f2 \u00e9s necessari habitualment per als nous tractaments m\u00e8dics abans que puguin ser aprovats per al seu \u00fas est\u00e0ndard i regular.
Si aquests assajos tenen \u00e8xit, TherVacB podria convertir-se en la primera vacuna que aconsegueixi una cura funcional per a l’hepatitis B.<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
La vacuna TherVacBQuan estar\u00e0 disponible la ter\u00e0pia per als pacients? L’assaig cl\u00ednic presentat anteriorment forma part del projecte TherVacB de la UE. \u00c9s el primer pas per provar la seguretat i l’efic\u00e0cia de la ter\u00e0pia en persones amb hepatitis B cr\u00f2nica. Si aquest assaig t\u00e9 \u00e8xit, seguiran m\u00e9s assajos cl\u00ednics (fase II i III) per […]<\/p>\n","protected":false},"author":4,"featured_media":4928,"parent":8168,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-8177","page","type-page","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t